Skip to main content
. Author manuscript; available in PMC: 2013 Jan 1.
Published in final edited form as: Neurobiol Aging. 2010 Mar 31;33(1):75–82. doi: 10.1016/j.neurobiolaging.2010.02.005

Table 1.

Characteristics of AD subjects and controls.

Characteristic AD Group Control Group
Number of subjects 17 17
Mean age ± std 70.5 ± 8.3 68.7 ± 8.4
Gender
 Male 13 7
 Female 4 10
Education (years) ± std 15.9 ± 2.5 16.5 ± 2.5
MMSEa score ± std 22.8 ± 4.1 29.6 ± 0.7
ApoE4 carrier 10/17 6/17
Cardiovascular risk factorsb ± std 2.2 ± 0.9 1.6 ± 1.3
Cholesterol lowering medications 14/17 8/17
Antihypertensive medicationsc 14/17 7/17
a

Mini-mental State Exam

b

See text for definition of the risk factor score.

c

Includes beta blocker, calcium channel blocker, angiotensin inhibitor, angiotensin converting enzyme inhibitor, and diuretics.